Understanding the links between cardiovascular disease and Parkinson's disease

被引:92
|
作者
Potashkin, Judy [1 ]
Huang, Xuemei [2 ,3 ]
Becker, Claudia [4 ]
Chen, Honglei [5 ]
Foltynie, Thomas [6 ]
Marras, Connie [7 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL USA
[2] Penn State Coll Med, Translat Brain Res Ctr, Hershey, PA USA
[3] Penn State Coll Med, Dept Neurol, Hershey, PA USA
[4] Univ Basel, Basel Pharmacoepidemiol Unit, Div Clin Pharm & Epidemiol, Dept Pharmaceut Sci, Basel, Switzerland
[5] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA
[6] UCL, Inst Neurol, Dept Clin & Movement Neurosci, Queen Sq, London, England
[7] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinsons Res, Toronto, ON, Canada
关键词
cardiovascular; Parkinson's disease; pathogenesis; risk factors; C-REACTIVE PROTEIN; RECREATIONAL PHYSICAL-ACTIVITY; VASCULAR RISK-FACTORS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; BRAIN CHOLESTEROL; PLASMA CERAMIDES; LDL-CHOLESTEROL;
D O I
10.1002/mds.27836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research. (c) 2019 International Parkinson and Movement Disorder Society
引用
收藏
页码:55 / 74
页数:20
相关论文
共 50 条
  • [31] Revisiting the links between glycaemia, diabetes and cardiovascular disease
    Sattar, N.
    DIABETOLOGIA, 2013, 56 (04) : 686 - 695
  • [32] Up in the air: links between the environment and cardiovascular disease
    Muenzel, Thomas
    CARDIOVASCULAR RESEARCH, 2019, 115 (13) : E144 - E146
  • [33] Cardiovascular autonomic dysfunction in Parkinson's disease
    Ziemssen, Tjalf
    Reichmann, Heinz
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) : 74 - 80
  • [34] The deterioration of cardiovascular reflexes in Parkinson's disease
    Mesec, A
    Sega, S
    Trost, M
    Pogacnik, T
    ACTA NEUROLOGICA SCANDINAVICA, 1999, 100 (05): : 296 - 299
  • [35] Cardiovascular Psychophysiology Altered in Parkinson's Disease
    Agudelo, Christian
    Jennings, J. Richard
    Ryan, John P.
    Jain, Samay
    ANNALS OF NEUROLOGY, 2014, 76 : S37 - S38
  • [36] Understanding the molecular causes of Parkinson's disease
    Wood-Kaczmar, A.
    Gandhi, S.
    Wood, N. W.
    TRENDS IN MOLECULAR MEDICINE, 2006, 12 (11) : 521 - 528
  • [37] Editorial: Molecular Links Between Mitochondrial Damage and Parkinson's Disease and Related Disorders
    Imai, Yuzuru
    Kim, Kiyoung
    Wu, Zhihao
    Sato, Shigeto
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Cardiovascular effects of levodopa in Parkinson's disease
    Noack, Cornelia
    Schroeder, Christoph
    Heusser, Karsten
    Lipp, Axel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (08) : 815 - 818
  • [39] Understanding the Lexicon of Fatigue in Parkinson's Disease
    Mantri, Sneha
    Klawson, Emily
    Albert, Steven
    Nabieva, Karina
    Lepore, Madeline
    Kahl, Stephen
    Daeschler, Margaret
    Mamikonyan, Eugenia
    Kopil, Catherine
    Marras, Connie
    Chahine, Lana M.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (03) : 1185 - 1193
  • [40] Cardiovascular Safety of Nilotinib in Parkinson's Disease
    Tan, Sean
    Baggio, Diva
    Shortt, Jake
    Ko, Brian
    MOVEMENT DISORDERS, 2021, 36 (09) : 2217 - 2217